Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Unifuzol in Healthy Volunteers
NCT03028285Phase 1Completed
- Sponsor
- POLYSAN
- Start
- Jul 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of arginine sodium succinate in peripheral vascular disease (PVD) (3 arms), sponsored by POLYSAN. Primary endpoint: Incidence of treatment-related adverse events, derangements of vital signs, and laboratory abnormalities. Started Jul 2016; status: completed.
02
Drugs
arginine sodium succinate
03
Conditions
peripheral vascular disease (PVD)
Beyond the preview
Go deeper on NCT03028285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028285.